Pod Engine
Podcast thumbnail for 340B Pulse

340B Pulse

Claim This Podcast

by NorthArcHealth

10 episodes
Updated Daily
Accepts GuestsHas Sponsors

Podcast Overview

340B Pulse is a NorthArc Health podcast powered by PureLogics. Built on nearly two decades of experience developing healthcare systems, data platforms, and compliance-driven environments, this podcast focuses on the real operational side of 340B including claims validation, reporting gaps, manufacturer requirements like ESP and Beacon, and program defensibility. This is not about noise or high-level theory. It’s about operator-level conversations — how 340B programs actually function, where friction shows up, and what it takes to run them effectively in the real world.

Language

🇺🇲

Publishing Since

4/3/2026

Visit WebsiteAppleView on Apple PodcastsRSS Feed

2 verified contact emails on file for 340B Pulse

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

See contact details

Recent Episodes

Episode thumbnail for The Hidden Financial Risk of Pharmacy: Why CFOs Must Pay Attention | Fatimah Muhammad

June 8, 2026

The Hidden Financial Risk of Pharmacy: Why CFOs Must Pay Attention | Fatimah Muhammad

<p>Pharmacy financial risk is the operational and reimbursement exposure inside health systems when 340B capture gaps, specialty drug economics, PBM pressure, and revenue cycle disconnects stay invisible to executive leadership until margin compression becomes obvious. Fatimah Muhammad, FHFMA, CHFP, explains why pharmacy has become a strategic financial partner, not a downstream clinical function, and why CFOs can no longer afford to stay on the sidelines of pharmacy strategy, 340B stewardship, and cross-functional visibility.340B Pulse is a NorthArc Health podcast powered by PureLogics, built for operator-level conversations about how pharmacy, 340B, and reimbursement actually function day to day.In this episode, hosts Muhammad Atif and Nadia Palwasha are joined by Fatimah Muhammad, FHFMA, CHFP, a healthcare executive and public health leader with more than 15 years of experience across 340B strategy, specialty pharmacy, reimbursement optimization, operational excellence, and healthcare financial performance.Fatimah unpacks the hidden financial risk of pharmacy: where operational leakage hides before executive dashboards reflect it, why pharmacy decisions are now enterprise financial decisions, and what CFOs and executive leaders should review monthly instead of waiting for audits or revenue decline.You will hear practical guidance on 340B as revenue cycle strategy, specialty pharmacy opportunity and risk, contract pharmacy economics, PBM and reimbursement pressure, cross-functional alignment across pharmacy, finance, revenue cycle, managed care, and compliance, analytics for earlier risk detection, balancing margin and access, and a 90-day starting framework for executive leaders.0:00:00 Welcome and episode framing: hidden pharmacy financial risk 0:03:15 Co-host introduction: Nadia Palwasha 0:04:45 Guest introduction: Fatimah Muhammad 0:06:10 Guest journey into 340B, specialty pharmacy, and financial performance 0:10:05 Defining hidden financial risk in pharmacy 0:11:18 Why CFOs cannot stay on the sidelines 0:12:45 Operational leakage and executive blind spots 0:13:35 Three CFO visibility pillars: 340B, specialty, contract pharmacy 0:14:22 Executive dashboards and missing operational reality 0:18:30 340B evolution: compliance to revenue cycle strategy 0:23:10 Specialty pharmacy opportunity and risk 0:25:40 Pharmacy reimbursement invisible on standard financial reports 0:28:15 PBM pressures, patient access, and sustainability 0:30:45 Cross-functional alignment: pharmacy, finance, revenue cycle, compliance 0:32:18 Strategic vs reactive pharmacy management signals 0:37:05 Analytics, automation, and earlier risk detection 0:40:20 Balancing financial performance with access and equity 0:44:10 90-day practical steps for CFOs and executive leaders 0:46:30 How to connect with Fatimah Muhammad 0:47:15 Closing and NorthArc CTA<strong>What is pharmacy financial risk? </strong>Pharmacy financial risk is the hidden operational and reimbursement exposure health systems face when 340B capture gaps, specialty drug economics, PBM pressure, denials, and workflow disconnects accumulate without executive visibility.<strong>Why should CFOs engage in pharmacy strategy?</strong>CFOs should engage because pharmacy sits at the intersection of 340B program performance, specialty service-line economics, contract pharmacy terms, and reimbursement recovery, all of which directly affect enterprise margin and sustainability.<strong>What should executives review in the next 90 days? </strong>Executives should establish shared visibility into what 340B is generating, how specialty pharmacy margins are performing, whether contract pharmacy economics are actively managed, and a monthly cross-functional review cadence with clear accountability.#340B program, #pharmacy financial risk,#hospital finance, CFO, #specialty pharmacy, #contract pharmacy, #revenue cycle, #PBM</p>

Episode thumbnail for Turning 340B Savings into Patient Access: The Mission Impact Debate | Kalvin Pugh

June 1, 2026

Turning 340B Savings into Patient Access: The Mission Impact Debate | Kalvin Pugh

<p>340B Pulse is a NorthArc Health podcast powered by PureLogics, built for operator-level conversations about how the 340B program actually runs day to day.In this episode, hosts Muhammad Atif and Nadia Palwasha are joined by Kalvin Pugh, 340B Policy Director, for a grounded conversation on turning 340B savings into mission impact. The discussion explores what happens when savings move beyond financial accounting into real support for low-income, uninsured, and under-resourced patients; the tension between program intent and operational pressure; the gap between savings generated and impact demonstrated; impact versus visibility; patient-level experience in community systems; operational constraints including data and contract pharmacy complexity; evolving frameworks for measuring mission impact; storytelling versus financial reporting; policy standardization; and practical alignment across manufacturers, pharmacies, and covered entities.If your organization needs stronger reporting visibility, operational alignment, and custom agentic automation with compliance guardrails, NorthArc Health helps covered entities modernize 340B operations without losing operator control.0:00:00 Welcome to 340B Pulse and episode framing0:02:20 Co-host intro: 340B savings and patient impact 0:04:10 Guest introduction: Kalvin Pugh0:06:20 Kalvin's journey into 340B and policy0:09:00 Defining "turning savings into mission impact" 0:11:30 Biggest gap: savings generated vs. impact demonstrated 0:14:00 What separates organizations with visible patient impact0:16:30 Impact vs. visibility under manufacturer transparency pressure0:19:30 What patients feel when 340B savings work well 0:22:00 Policy debate vs. patients the program was meant to serve 0:24:30 Challenges translating savings into measurable mission impact 0:27:00 Operational constraints: data, contract pharmacy, reporting 0:29:30 Are mission-impact frameworks mature enough? 0:32:00 Policy intent vs. community-level reality 0:34:30 Patient stories vs. purely financial reporting0:37:00 Policy leaders and standardizing mission impact 0:39:00 Designing a system that connects savings to outcomes 0:39:45 Industry context: AHA pushback on Lilly claims-data policy 0:41:00 Rapid-fire: tracking savings, standardized reporting, future policy 0:43:30 Closing advice: human intent across the 340B ecosystem 0:44:30 How to connect with Kalvin PughWhat is 340B mission impact? 340B mission impact is the measurable patient and community benefit when covered entities use program savings to improve access, continuity of care, and services for vulnerable populations served by safety-net providers.Why is 340B mission impact hard to prove? 340B mission impact is hard to prove because reporting frameworks vary by entity type, data is fragmented across operations, and rising manufacturer transparency requirements add administrative burden that can compete with patient-facing capacity.Is 340B a pricing program or a patient access program? 340B is a federal drug pricing program that covered entities should also treat as a patient access program because its savings are intended to expand care and reduce barriers for underserved populations, not only to improve institutional finances.#340B #340BProgram #PatientAccess #SafetyNet #CoveredEntity #HealthcareCompliance #ContractPharmacy #FQHC #HospitalPharmacy #NorthArcHealth #340BPulse</p>

Episode thumbnail for Claims-Level Data Challenges in 340B: Pharmacy & Medical | Bryan McCormick

May 25, 2026

Claims-Level Data Challenges in 340B: Pharmacy & Medical | Bryan McCormick

<p>340B claims-level data is the patient- and claim-level information covered entities must reconcile across split billing, contract pharmacy, TPAs, EHR outputs, and wholesaler feeds to defend eligibility and program performance. Bryan McCormick explains that most organizations do not have one source of truth, because retail partner mandates can force multiple TPAs, split billing and contract pharmacy remain separate operational worlds, and compliance accountability still rests with the covered entity even when vendors process claims.</p><p><br>340B Pulse is a NorthArc Health podcast powered by PureLogics, built for operator-level conversations about how the 340B program actually runs day to day.</p><p>In this episode, host Muhammad Atif is joined by Bryan McCormick, Corporate Director of the 340B Program at RWJBarnabas Health. Bryan unpacks claims-level data challenges across pharmacy and medical-related 340B workflows, including TPA configuration accountability, multi-TPA aggregation burden, split billing versus contract pharmacy separation, garbage-in/garage-out feed discipline, EHR governance, real-world connectivity failures, reconciliation and root-cause expectations, staffing realities for safety-net hospitals, manufacturer portal fragmentation (ESP and related channels), and a practical view of AI and vendor sprawl.</p><p>If your organization needs stronger claims validation, reporting visibility, and custom agentic automation with compliance guardrails, NorthArc Health helps covered entities modernize 340B operations without losing operator control.</p><p><br>0:00:00 TPA configuration is a covered-entity compliance decision </p><p>0:01:08 Multi-TPA reality: Walgreens, CVS, and aggregation burden </p><p>0:03:25 Why leadership reports must be 100% accurate </p><p>0:04:18 Pharmacy vs medical claims fragmentation in 340B </p><p>0:04:38 Split billing vs contract pharmacy: two separate worlds </p><p>0:07:15 Garbage in, garbage out and roster discipline</p><p>0:09:27 PBMs, TPAs, EHR: volume, variability, and fragmentation </p><p>0:10:20 Stakeholder forums and EHR as source of truth </p><p>0:12:19 Compliance accountability always on the covered entity </p><p>0:13:30 Where data breakdowns occur in handoffs </p><p>0:14:21 Pharmacy switch outage case (2024 backlog impact) </p><p>0:16:21 Operational impact on eligibility, accumulation, and reporting </p><p>0:17:33 Monitoring volume and vendor value </p><p>0:19:57 Identification, tracking, and read-only access </p><p>0:21:21 Reconciliation, escalation, and self-disclosure thresholds </p><p>0:23:29 Scaling, Epic + Verity integration, and KISS operations </p><p>0:27:19 Dedicated 340B FTEs and policy volatility </p><p>0:28:34 Manufacturer portals: ESP, restrictions, no global playbook </p><p>0:30:09 Human review before external manufacturer submissions </p><p>0:31:27 AI potential vs integration and PHI risk </p><p>0:33:22 More vendors means more integration to police </p><p>0:34:36 Practical advice: plug-and-play is over</p><p>0:38:05 Stakeholder meetings and how to connect with Bryan</p><p><br><strong>What is 340B claims-level data? </strong></p><p>340B claims-level data is the detailed claim, eligibility, and feed information covered entities use to run split billing and contract pharmacy workflows, validate vendor outputs, and support compliance, financial reporting, and audit defensibility.</p><p><br></p><p><strong>Why do covered entities use multiple TPAs? </strong></p><p>Covered entities often use multiple TPAs because major retail contract pharmacy partners may require their own systems while a primary TPA still supports split billing and other contract relationships, which forces manual aggregation before holistic reporting.</p><p><strong>Who owns 340B data accuracy when vendors process claims?</strong> </p><p>The covered entity owns compliance and performance accountability in most vendor relationships, which means teams must validate what they send to TPAs and what vendors return before leadership or external reporting.</p><p><br>#340B program,#claims data, #pharmacy operations, #healthcare compliance, #split billing,#contract pharmacy, #TPA, #EHR integration, #healthcare data</p>

10 total episodes available

Similar Podcasts

Discover related shows you might enjoy

Podcast thumbnail for 340B 360

340B 360

340B Report

Podcast thumbnail for 340B Insight

340B Insight

340B Health

Podcast thumbnail for Inside 340B Report

Inside 340B Report

340B Report

Podcast thumbnail for Pharmacy Innovators Podcast

Pharmacy Innovators Podcast

Visante Consulting

Deep-dive analytics for 340B Pulse

Sign up to explore

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is 340B Pulse?

340B Pulse is a NorthArc Health podcast powered by PureLogics.

Built on nearly two decades of experience developing healthcare systems, data platforms, and compliance-driven environments, this podcast focuses on the real operational side of 340B including claims validation, reporting gaps, manufacturer requirements like ESP and Beacon, and program defensibility.

This is not about noise or high-level theory.

It’s about operator-level conversations — how 340B programs actually function, where friction shows up, and what it takes to run them effectively in the real world.

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.